Instrument Inactif

Autres langues MDxHealth SA Euronext Bruxelles

Actions

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	12/03
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	12/03
MDxHealth SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	06/03
Earnings Flash (MDXH) MDXHEALTH Posts Q4 Revenue $19.4M	06/03
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results	06/03
MDxHealth SA Maintains Earnings Guidance for the Year 2024	06/03
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6	21/02
Mdxhealth Announces Resignation of Board Member	16/02
MDxHealth SA Announces Jan Pensaert Steps Down from its Board of Directors	16/02
MDxHealth Preliminary Q4 Revenue Tops Consensus; 2024 Outlook Exceeds Estimates; Shares Jump After Hours	08/01
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance	08/01
MDxHealth SA Provides Earnings Guidance for the Fourth Quarter and Full Year 2023 and Year 2024	08/01

Aucun résultat pour cette recherche